Burke Jennifer M, Ganley-Leal Lisa M, Khatri Asma, Wetzler Lee M
Department of Pathology, Boston University School of Medicine, Boston, MA 02118, USA.
J Immunol. 2007 Sep 1;179(5):3222-30. doi: 10.4049/jimmunol.179.5.3222.
Efficacious adjuvants are important components of new vaccines. The neisserial outer membrane protein, PorB, is a TLR2 ligand with unique adjuvant activity. We demonstrate that PorB promotes Th2-skewed cellular immune response to the model Ag, OVA, in mice, including Ag-specific recall eosinophil recruitment to the peritoneum. PorB induces chemokine secretion by myeloid cells using both TLR2-dependent and -independent mechanisms, suggesting that anatomical distribution of TLR2(+) cells may not be a limiting factor for potential vaccine strategies. The results from this study suggest that PorB, and other TLR2 ligands, may be ideal for use against pathogens where eosinophilia may be protective, such as parasitic helminths.
有效的佐剂是新型疫苗的重要组成部分。奈瑟菌外膜蛋白PorB是一种具有独特佐剂活性的Toll样受体2(TLR2)配体。我们证明,PorB可促进小鼠对模型抗原OVA产生偏向Th2的细胞免疫反应,包括抗原特异性回忆性嗜酸性粒细胞募集至腹膜。PorB通过TLR2依赖性和非依赖性机制诱导髓样细胞分泌趋化因子,这表明TLR2阳性细胞的解剖分布可能不是潜在疫苗策略的限制因素。本研究结果表明,PorB和其他TLR2配体可能是对抗嗜酸性粒细胞增多具有保护作用的病原体(如寄生性蠕虫)的理想选择。